Genetic Alterations Of ALK In Patients With High-Risk Neuroblastoma Demonstrated Utility As Independent Predictors Of Poorer Survival, Study Finds

Healio (7/7, Lawrence) reports, “Genetic alterations of ALK, including clonal mutations and amplifications, in high-risk neuroblastoma demonstrated utility as independent predictors of poorer survival, according to a study.” The findings were published in...